Black Bird Biotech, Inc. (BBBT)

Market Cap	3.73K -98.8%
Revenue (ttm)	36.32K -61.0%
Net Income	-836.14K
EPS	-0.00
Shares Out	3.73B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	35,470
Average Volume	2,690,024
Open	0.0000
Previous Close	0.0000
Day's Range	0.0000 - 0.0000
52-Week Range	0.0000 - 0.0001
Beta	2.01
RSI	44.14
Earnings Date	Mar 20, 2026

About Black Bird Biotech

Black Bird Biotech Inc. provides various biotech products. It manufactures and distributes MiteXstream, a plant-based biopesticide for the eradication of spider mites. The company also manufactures and sells CBD Oils, gummies and pet treats, CBD-infused personal care products, and hand sanitizer under the Grizzly Creek Naturals brand name. In addition, it grows industrial hemp under the Montana Hemp pilot program. The company was formerly known as Digital Development Partners, Inc. and changed its name to Black Bird Biotech, Inc. in June 2021. ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Nelson Grist
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: BBBT

Financial Performance

In 2022, Black Bird Biotech's revenue was $82,563, a decrease of -20.96% compared to the previous year's $104,458. Losses were -$1.66 million, -8.42% less than in 2021.